GILD vs MVBF · P/E 18, rev $7.80B vs P/E 12, rev $93.4M
Gilead Sciences Inc (GILD) versus MVB Financial Corp (MVBF) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
MVB Financial Corp (MVBF) is a banks - regional company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported MVBF revenue for 2026-06-30 was $93.4M. Net income was $17.4M. MVBF currently screens at market cap $337.7M and trailing P/E 12.1.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. MVBF currently screens at market cap $337.7M and trailing P/E 12.1.
Not investment advice. Open the GILD and MVBF stock pages for the full models.
Not investment advice.